News Daily News Collateral Flow Associated with Angiographic, Clinical Outcomes in Acute Stroke Patients Yael L. Maxwell February 05, 2014
News Daily News Bioresorbable Scaffolds Show Promise in Select STEMI Patients Yael L. Maxwell January 09, 2014
News Daily News Post Angiography Testosterone Therapy Increases Cardiovascular Events in High-Risk Men December 05, 2013
News Daily News El Tratamiento con Testosterona Post-Angiografía aumenta los Episodios Cardiovasculares en Varones de Alto Riesgo December 05, 2013
News Industry News OrbusNeich’s COMBO™ Dual Therapy Stent Shows Excellent Early Healing and Durable Outcomes out to 24 Months October 29, 2013
News Industry News Arterial Remodeling Technologies (‘ART’) reports 30-day results for the ‘ARTDIVA’ clinical trial of its next-generation bioresorbable stent at ‘TCT 2013’ annual scientific meeting October 28, 2013
News Daily News DESSOLVE I: Bioabsorbable Polymer SES Shows Promise in De Novo Lesions Yael L. Maxwell September 20, 2013
News Conference News ESC 2013 Cooling, PCI Improves Long-term Outcomes for Cardiac Arrest Survivors Yael L. Maxwell September 04, 2013
News Daily News TRILOGY ACS Substudy: Prasugrel Post-Angiography Minimizes Risk of Adverse Events Yael L. Maxwell August 23, 2013
News Daily News Subestudio del TRILOGY ACS: El Prasugrel Post-Angiografía Minimiza el Riesgo de Episodios Adversos Yael L. Maxwell August 23, 2013
News Daily News Performance of Bioabsorbable Scaffold Can Be Tracked with Noninvasive CT August 08, 2013
News Daily News El Rendimiento de un Andamio Biorreaborbible puede Evaluarse mediante una TC No Invasiva August 08, 2013
News Daily News Un Nuevo Marcador de la Inflamación Urinaria Ajusta el Pronóstico de la EAC Estable August 05, 2013
News Daily News La Angiografía podría Sobrevalorar la Severidad de la Enfermedad frente a la FFR en las Mujeres Caitlin E. Cox June 20, 2013
News Daily News Angiography May Overestimate Disease Severity vs. FFR in Women Caitlin E. Cox June 20, 2013
News Industry News Elixir Medical Corporation to Announce 6-month Results of the DESolve Fully Bioresorbable Coronary Scaffold System Pivotal Trial at Late Breaking Trial Session of EuroPCR May 01, 2013